JAG
AMGN icon

Journey Advisory Group’s Amgen AMGN Stock Holding History

Journey Advisory Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.22M Sell
6,303
-626
-9% -$223K 0.19% 107
2025
Q4 		$2.27M Sell
6,929
-303
-4% -$96.1K 0.19% 112
2025
Q3 		$2.04M Sell
7,232
-1,142
-14% -$331K 0.15% 116
2025
Q2 		$2.34M Sell
8,374
-169
-2% -$47.9K 0.18% 117
2025
Q1 		$2.66M Sell
8,543
-17,620
-67% -$5.2M 0.22% 104
2024
Q4 		$8.17M Hold
26,163
– – 0.98% 29
2024
Q3 		$8.17M Hold
26,163
– – 0.98% 29
2024
Q2 		$8.17M Buy
26,163
+1,197
+5% +$352K 0.98% 29
2024
Q1 		$7.1M Buy
24,966
+2,223
+10% +$650K 0.87% 33
2023
Q4 		$6.55M Buy
22,743
+327
+1% +$89.1K 0.89% 32
2023
Q3 		$6.02M Buy
22,416
+791
+4% +$197K 0.9% 32
2023
Q2 		$4.8M Buy
21,625
+617
+3% +$143K 0.71% 42
2023
Q1 		$5.08M Buy
21,008
+4,010
+24% +$984K 0.8% 34
2022
Q4 		$4.46M Buy
16,998
+5,406
+47% +$1.45M 1.11% 22
2022
Q3 		$2.61M Buy
11,592
+1,665
+17% +$404K 0.67% 40
2022
Q2 		$2.44M Buy
9,927
+3,046
+44% +$746K 0.56% 45
2022
Q1 		$1.66M Buy
6,881
+1,351
+24% +$310K 0.42% 60
2021
Q4 		$1.24M Buy
5,530
+1,450
+36% +$306K 0.34% 70
2021
Q3 		$868K Buy
4,080
+1,089
+36% +$251K 0.28% 82
2021
Q2 		$729K Buy
2,991
+624
+26% +$154K 0.23% 96
2021
Q1 		$589K Buy
2,367
+158
+7% +$37.7K 0.21% 99
2020
Q4 		$508K Buy
+2,209
New +$509K 0.19% 100

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Journey Advisory Group's AMGN Position: Q1 2026 in Review

Journey Advisory Group reduced its Amgen (AMGN) stake by 9% in Q1 2026, selling an estimated $223K and leaving 6,303 shares worth $2.22M. The position accounts for 0.19% of the portfolio, ranked #107.

Journey Advisory Group first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. The position peaked at $8.17M in Q4 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Journey Advisory Group held 6,303 shares of Amgen worth $2.22M as of Q1 2026.
  • Journey Advisory Group sold 626 Amgen shares in Q1 2026, an estimated $223K.
  • Amgen made up 0.19% of Journey Advisory Group's portfolio in Q1 2026, its #107 holding.
  • Journey Advisory Group first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
  • Journey Advisory Group's Amgen position peaked at $8.17M in Q4 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Journey Advisory Group's 13F filing for Q1 2026, filed 5 May 2026.